Small-Joint Reconstructive Implants – Market Insights – Europe

The European reconstructive small-joint market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward, growth will be driven by high growth in certain subsegments, such as those for shoulder and total ankle arthroplasty. Adoption of small-joint reconstructive implants is rising due to favorable clinical results, a favorable reimbursement environment in Europe, and an expanding pool of trained surgeons, while high product ASPs, supported by ongoing product innovation and comparatively low pricing pressure in this underpenetrated market, will further contribute to strong revenue expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the global market for small-joint reconstructive implants from 2019 through 2032.

Technological innovation will have a significant impact on the European small-joint reconstructive implant market.

How will the launch of new implants impact the market?

How are companies reacting to the trends surrounding navigation technologies and personalized implants?

The shoulder segment continues to exhibit strong growth.

What factors are driving procedure volume and revenue growth in this segment?

Which companies lead the shoulder segment, and what innovations are they focusing on?

Which countries will exhibit the fastest growth in this segment?

Large competitors have entrenched market shares.

How are the leading competitors leveraging their positions in the market to maintain their market shares?

What strategies can smaller competitors use to gain market share?

Which product segments should competitors focus on for growth opportunities?

Table of contents